Scripta Therapeutics Limited

Scripta Therapeutics is an Oxford-based biotech company using AI and imaging to target transcription factors, the 'master controllers' of gene expression.

Headquarters

Oxford, UK

Year Founded

2024

Founders

Dr. Emily Carter

Country

United Kingdom

Financial Information

Funding Stage

Seed

Recent Funding

$12 Million

Funding By

Oxford Science Innovation

Core Technology

AI transcription factor targeting

Product Type

Drug

Pipeline Stage (Very Important)

Discovery

Regulatory Status

IND Filed: No
FDA/EMA Status: N/A
Clinical Trial Registration: N/A
Patents / IP Status: Filed

Partnerships

Pharma Collaborations

None

Academic / Hospital Tie-ups

Oxford University

CRO/CDMO Partnerships

None

Market & Differentiation

AI for gene regulation